CYBN (cybin.com) Prakiraan pendapatan perusahaan

Logo grafis Cybin Corp (CYBN)

How can Cybin Inc. retain leading neurobiologists? The company's sales volume forecast reflects a trend where the metric value is 0.00. The solution lies in providing generous laboratory funding and outsourcing molecule synthesis to certified factories. Additionally, Cybin Inc. is accelerating the release of innovative psilocybin-based drugs, maximizing its research resources to combat depression.

CYBN - Volume dodolan mangsa ngarep perusahaan Cybin ing rentang 04.07.2022 - 05.01.2026

Rincian analitis perusahaan Cybin Corp (CYBN)

- kuotasi lan prakiraan analis:
Rega saham Cybin Inc.|CYBN - Konsensus nilai wajar
- indikator valuasi pasar bisnis:
Nilai pasar Cybin Inc|CYBN - Total Nilai Perusahaan
- data ekuitas miturut neraca:
Nilai Buku saben Saham Cybin|CYBN - Aset Bersih Perusahaan|Rasio Kapitalisasi marang Aset Bersih cybin.com|CYBN - Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Cybin Inc.|CYBN - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Cybin Inc.|CYBN - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Cybin Inc|CYBN - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Cybin|Rasio cepet cybin.com
- statistik bathi lan rasio pasar:
CYBN - Asil keuangan resik|Bathi sing dikarepake Cybin Inc.|CYBN - Pangali rega marang bathi|Pangali Forward P/E Cybin Inc.|CYBN - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cybin Inc|CYBN - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Cybin|CYBN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan cybin.com|CYBN - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Cybin Inc.
- data total pendapatan lan volume dodolan:
CYBN - Pendapatan perusahaan|Prakiraan pendapatan perusahaan Cybin Inc.|CYBN - Rasio kapitalisasi marang pendapatan|Rasio rega marang prakiraan pendapatan Cybin Inc
Analisis dhasar perusahaan:CYBN Cybin
Produk merek Cybin Corp

The market values Cybin Inc. (CYBN) through the lens of a shortage of effective antidepressants and the high potential of its innovative molecules currently in clinical trials. By analyzing the company's projected sales volumes, investors gain a real-time assessment of expected revenue which, unlike static reports, reflects the dynamics of the asset's fundamental value and allows for an evaluation of the business model's resilience during the development phase.

Karo sapa Cybin Inc. saingan

Prakiraan volume dodolan ALKS|AVDL (avadel.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan atai Life Sciences ATAI|GH Research plc (GHRS) - Volume dodolan sing dikarepake perusahaan|MindMed Inc. - Prakiraan volume dodolan|COMPASS Corp (CMPS) - Volume dodolan mangsa ngarep perusahaan|LBRX (LB Pharmaceuticals Inc) - Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan brightmindsbio.com (DRUG)|VNDA (Vanda Pharmaceuticals Inc.) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan ANRO|Prakiraan volume dodolan NRXP|Dodolan mangsa ngarep perusahaan cingulate.com|Prakiraan pendapatan perusahaan Silo Pharma SILO|CPHI: Prakiraan pendapatan perusahaan|CMND: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan PBM (Psyence Biomedical Ltd)|SPRC: Prakiraan volume dodolan|SEEL - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Virpax Pharmaceuticals Inc.|Prakiraan pendapatan perusahaan KRTX (karunatx.com)